Pharmacogenomics moves beyond single genes to predict drug response

A new review argues that personalized medicine needs to account for complex genetic interactions, not just isolated variants. The shift could reshape how pharmaceutical companies design clinical trials and how healthcare systems implement precision treatments, potentially improving drug efficacy and reducing adverse effects across patient populations.

Originaltitel: Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward